FDA: Animal Testing No Longer Mandatory before Human Trials
Swathi Kodaikal, MSc
New FDA law is a “radical shift” in the field of pharmaceutical research and drug development
Drug Testing
Organ-on-a-Chip: A Personalized Approach to In Vitro Modeling
Jake Moskowitz, DVM, PhD
Integrated cell culture and microfluidics provide platforms for research, drug testing, and personalized medicine
Novel Psychoactive Substances: Testing Challenges and Strategies
Pallavi Upadhyay, PhD
To keep up with emerging NPS, toxicology labs must develop robust assays and update existing testing panels and menus
Mobile Drug Testing: Driving the Future of Compliance Drug Monitoring
Pallavi Upadhyay, PhD
Mobile testing frameworks could help deliver better health care to underserved communities
Innovations in Clinical Trial Design
Erica Tennenhouse, PhD
Matthew M. Laughon, MD, MPH is a professor at the University of North Carolina (UNC) at Chapel Hill in the
department of pediatrics.
department of pediatrics.
How to Detect Tampered Drug Tests
Raeesa Gupte, PhD
As drug test adulteration becomes more sophisticated, so do detection methods
How Long Do Drugs Stay in the Body?
Today's Clinical Lab
Duration depends on the biological matrix